<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32041109</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Local and Systemic Humoral Response to Autologous Lineage-Negative Cells Intrathecal Administration in ALS Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1070</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21031070</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) remains a fatal disease with limited therapeutic options. Signaling via neurotrophins (NTs), neuroinflammation, and certain micro-RNAs are believed to play essential role in ALS pathogenesis. Lineage-negative stem/progenitor cells (Lin<sup>-</sup>) were obtained from bone marrow of 18 ALS patients and administered intrathecally. Clinical assessment was performed using ALS Functional Rating Scale (FRSr) and Norris scale. Protein concentrations were measured in plasma and cerebrospinal fluid (CSF) by multiplex fluorescent bead-based immunoassay. Gene expression in nucleated blood cells was assessed using gene microarray technique. Finally, miRNA expression was analyzed using qPCR in CSF and plasma samples. We observed a significant decrease of C-reactive protein (CRP) concentration in plasma on the seventh day from the application of cells. Gene array results revealed decreased expression of gene sets responsible for neutrophil activation. Further analysis revealed moderate negative correlation between CRP level in CSF and clinical outcome. Brain-derived neurotrophic factor (BDNF) concentrations in both plasma and CSF significantly correlated with the favorable clinical outcome. On a micro-RNA level, we observed significant increase of miR-16-5p expression one week after transplantation in both body fluids and significant increase of miR-206 expression in plasma. Administration of Lin<sup>-</sup> cells may decrease inflammatory response and prevent neurodegeneration. However, these issues require further investigations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baumert</LastName><ForeName>Bart&#x142;omiej</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-9933-5844</Identifier><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobu&#x15b;</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Go&#x142;&#x105;b-Janowska</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Pomeranian Medical University, 71-252 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ula&#x144;czyk</LastName><ForeName>Zofia</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-0451-8723</Identifier><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paczkowska</LastName><ForeName>Edyta</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7052-9741</Identifier><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x141;uczkowska</LastName><ForeName>Karolina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4008-7473</Identifier><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zawi&#x15b;lak</LastName><ForeName>Alicja</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2036-2853</Identifier><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milczarek</LastName><ForeName>S&#x142;awomir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Os&#x119;kowska</LastName><ForeName>Bogumi&#x142;a</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meller</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Pomeranian Medical University, 71-252 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machowska-Sempruch</LastName><ForeName>Karolina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Pomeranian Medical University, 71-252 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>We&#x142;nicka</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Pomeranian Medical University, 71-252 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Safranow</LastName><ForeName>Krzysztof</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9415-2758</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nowacki</LastName><ForeName>Przemys&#x142;aw</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Pomeranian Medical University, 71-252 Szczecin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machali&#x144;ski</LastName><ForeName>Bogus&#x142;aw</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of General Pathology, Pomeranian Medical University, 70-111 Szczecin, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>STRATEGMED1/234261/2NCBR/2014</GrantID><Agency>National Centre for Research and Development, Poland</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C505362">MIRN16 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C546087">MIRN206 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>7171WSG8A2</RegistryNumber><NameOfSubstance UI="C579455">BDNF protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019208" MajorTopicYN="N">Brain-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019070" MajorTopicYN="N">Cell Lineage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056724" MajorTopicYN="N">Immunity, Humoral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007278" MajorTopicYN="N">Injections, Spinal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033581" MajorTopicYN="N">Stem Cell Transplantation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">gene microarrays</Keyword><Keyword MajorTopicYN="N">inflammatory response</Keyword><Keyword MajorTopicYN="N">lineage-negative cells</Keyword><Keyword MajorTopicYN="N">neurotrophins</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32041109</ArticleId><ArticleId IdType="pmc">PMC7037134</ArticleId><ArticleId IdType="doi">10.3390/ijms21031070</ArticleId><ArticleId IdType="pii">ijms21031070</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Niedermeyer S., Murn M., Choi P.J. Respiratory Failure in Amyotrophic Lateral Sclerosis. Chest. 2018;155:401&#x2013;408. doi: 10.1016/j.chest.2018.06.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2018.06.035</ArticleId><ArticleId IdType="pubmed">29990478</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Hardiman O. The epidemiology of ALS: A conspiracy of genes, environment and time. Nat. Rev. Neurol. 2013;9:617&#x2013;628. doi: 10.1038/nrneurol.2013.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurland L.T., Mulder D.W. Epidemiologic investigations of amyotrophic lateral sclerosis. 2. Familial aggregations indicative of dominant inheritance. II. Neurology. 1955;5:249&#x2013;268. doi: 10.1212/WNL.5.4.249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.5.4.249</ArticleId><ArticleId IdType="pubmed">14370376</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters O.M., Ghasemi M., Brown R.H., Jr. Emerging mechanisms of molecular pathology in ALS. J. Clin. Investig. 2015;125:1767&#x2013;1779. doi: 10.1172/JCI71601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI71601</ArticleId><ArticleId IdType="pmc">PMC4463186</ArticleId><ArticleId IdType="pubmed">25932674</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., Traynor B.J., Hardiman O., Chi&#xf2; A., Mitchell D., Swingler R.J., Millul A., Benn E., Beghi E. Incidence of Amyotrophic Lateral Sclerosis in Europe. J. Neurol. Neurosurg. Psychiatry. 2010;81:385&#x2013;390. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaelson N., Facciponte D., Bradley W., Stommel E. Cytokine expression levels in ALS: A potential link between inflammation and BMAA-triggered protein misfolding. Cytokine Growth Factor Rev. 2017;37:81&#x2013;88. doi: 10.1016/j.cytogfr.2017.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2017.05.001</ArticleId><ArticleId IdType="pubmed">28532674</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K., Jonsson P.A., Andersen P.M., Bergemalm D., Graffmo K.S., Hultdin M., Jacobsson J., Rosquist R., Marklund S.L., Brannstrom T. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS ONE. 2010;5:e11552. doi: 10.1371/journal.pone.0011552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011552</ArticleId><ArticleId IdType="pmc">PMC2904380</ArticleId><ArticleId IdType="pubmed">20644736</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E.L., Chen H.J., Shaw C.E. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets. Neurotherapeutics. 2015;12:352&#x2013;363. doi: 10.1007/s13311-015-0338-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0338-x</ArticleId><ArticleId IdType="pmc">PMC4404432</ArticleId><ArticleId IdType="pubmed">25652699</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica R., De Vos K.J., Paillusson S., Mueller S., Sancho R.M., Lau K.F., Vizcay-Barrena G., Lin W.L., Xu Y.F., Lewis J., et al. ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat. Commun. 2014;5:3996. doi: 10.1038/ncomms4996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4996</ArticleId><ArticleId IdType="pmc">PMC4046113</ArticleId><ArticleId IdType="pubmed">24893131</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A., Canosa A., Bertuzzo D., Cugnasco P., Solero L., Clerico M., De Mercanti S., Bersano E., Cammarosano S., Ilardi A., et al. Influence of cigarette smoking on ALS outcome: A population-based study. J. Neurol. Neurosurg. Psychiatry. 2016;87:1229&#x2013;1233. doi: 10.1136/jnnp-2016-313793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-313793</ArticleId><ArticleId IdType="pubmed">27656044</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon M.S., Wosiski-Kuhn M., Gillespie R., Caress J., Milligan C. Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology. Muscle Nerve. 2019;59:10&#x2013;22. doi: 10.1002/mus.26289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26289</ArticleId><ArticleId IdType="pubmed">29979464</ArticleId></ArticleIdList></Reference><Reference><Citation>Almer G., Guegan C., Teismann P., Naini A., Rosoklija G., Hays A.P., Chen C., Przedborski S. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann. Neurol. 2001;49:176&#x2013;185. doi: 10.1002/1531-8249(20010201)49:2&lt;176::AID-ANA37&gt;3.0.CO;2-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(20010201)49:2&lt;176::AID-ANA37&gt;3.0.CO;2-X</ArticleId><ArticleId IdType="pubmed">11220737</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock B.J., Zhou T., Kashlan S.R., Little R.J., Goutman S.A., Feldman E.L. Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression. JAMA Neurol. 2017;74:1446&#x2013;1454. doi: 10.1001/jamaneurol.2017.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.2255</ArticleId><ArticleId IdType="pmc">PMC5822195</ArticleId><ArticleId IdType="pubmed">28973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Doble A. The pharmacology and mechanism of action of riluzole. Neurology. 1996;47:S233&#x2013;S241. doi: 10.1212/WNL.47.6_Suppl_4.233S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.47.6_Suppl_4.233S</ArticleId><ArticleId IdType="pubmed">8959995</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz M.P. Edaravone (Radicava): A Novel Neuroprotective Agent for the Treatment of Amyotrophic Lateral Sclerosis. Pharmacol. Ther. 2018;43:25&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5737249</ArticleId><ArticleId IdType="pubmed">29290672</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.G., Appel S.H. Introduction to supplement: The current status of treatment for ALS. Amyotroph. Lateral Scler. Front. Degener. 2017;18:1&#x2013;4. doi: 10.1080/21678421.2017.1361447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1361447</ArticleId><ArticleId IdType="pubmed">28872909</ArticleId></ArticleIdList></Reference><Reference><Citation>Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Macklin E.A., Lee A., Murphy A., Chang J., Zipf A., Cudkowicz M., Atassi N. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS) Amyotroph. Lateral. Scler. Front. Degener. 2014;15:453&#x2013;456. doi: 10.3109/21678421.2014.903974.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.903974</ArticleId><ArticleId IdType="pmc">PMC4433003</ArticleId><ArticleId IdType="pubmed">24981792</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunn J.S., Sakowski S.A., Feldman E.L. Stem cell therapies for amyotrophic lateral sclerosis: Recent advances and prospects for the future. Stem Cells. 2014;32:1099&#x2013;1109. doi: 10.1002/stem.1628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1628</ArticleId><ArticleId IdType="pmc">PMC4225704</ArticleId><ArticleId IdType="pubmed">24448926</ArticleId></ArticleIdList></Reference><Reference><Citation>Forraz N., Pettengell R., McGuckin C.P. Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC. Stem Cells. 2004;22:100&#x2013;108. doi: 10.1634/stemcells.22-1-100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/stemcells.22-1-100</ArticleId><ArticleId IdType="pubmed">14688396</ArticleId></ArticleIdList></Reference><Reference><Citation>Paczkowska E., Kaczynska K., Pius-Sadowska E., Roginska D., Kawa M., Ustianowski P., Safranow K., Celewicz Z., Machalinski B. Humoral activity of cord blood-derived stem/progenitor cells: Implications for stem cell-based adjuvant therapy of neurodegenerative disorders. PLoS ONE. 2013;8:e83833. doi: 10.1371/journal.pone.0083833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083833</ArticleId><ArticleId IdType="pmc">PMC3877125</ArticleId><ArticleId IdType="pubmed">24391835</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobus A., Baumert B., Litwinska Z., Golab-Janowska M., Stepniewski J., Kotowski M., Pius-Sadowska E., Kawa M.P., Grodecka-Szwajkiewicz D., Peregud-Pogorzelski J., et al. Safety and Feasibility of Lin-Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles. Int. J. Mol. Sci. 2018;19:1312. doi: 10.3390/ijms19051312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051312</ArticleId><ArticleId IdType="pmc">PMC5983708</ArticleId><ArticleId IdType="pubmed">29702606</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Terlizzi R., Platt S. The function, composition and analysis of cerebrospinal fluid in companion animals: Part I-function and composition. Vet. J. 2006;172:422&#x2013;431. doi: 10.1016/j.tvjl.2005.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tvjl.2005.07.021</ArticleId><ArticleId IdType="pubmed">16154365</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuckin C.P., Forraz N., Allouard Q., Pettengell R. Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro. Exp. Cell Res. 2004;295:350&#x2013;359. doi: 10.1016/j.yexcr.2003.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2003.12.028</ArticleId><ArticleId IdType="pubmed">15093735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bibel M., Barde Y.A. Neurotrophins: Key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 2000;14:2919&#x2013;2937. doi: 10.1101/gad.841400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.841400</ArticleId><ArticleId IdType="pubmed">11114882</ArticleId></ArticleIdList></Reference><Reference><Citation>Keefe K.M., Sheikh I.S., Smith G.M. Targeting Neurotrophins to Specific Populations of Neurons: NGF, BDNF, and NT-3 and Their Relevance for Treatment of Spinal Cord Injury. Int. J. Mol. Sci. 2017;18:548. doi: 10.3390/ijms18030548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18030548</ArticleId><ArticleId IdType="pmc">PMC5372564</ArticleId><ArticleId IdType="pubmed">28273811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda K., Klinkosz B., Greene T., Cedarbaum J.M., Wong V., Lindsay R.M., Mitsumoto H. Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann. Neurol. 1995;37:505&#x2013;511. doi: 10.1002/ana.410370413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410370413</ArticleId><ArticleId IdType="pubmed">7717687</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase G., Kennel P., Pettmann B., Vigne E., Akli S., Revah F., Schmalbruch H., Kahn A. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nat. Med. 1997;3:429&#x2013;436. doi: 10.1038/nm0497-429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0497-429</ArticleId><ArticleId IdType="pubmed">9095177</ArticleId></ArticleIdList></Reference><Reference><Citation>A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III) Neurology. 1999;52:1427&#x2013;1433. doi: 10.1212/WNL.52.7.1427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.52.7.1427</ArticleId><ArticleId IdType="pubmed">10227630</ArticleId></ArticleIdList></Reference><Reference><Citation>Price R.D., Milne S.A., Sharkey J., Matsuoka N. Advances in small molecules promoting neurotrophic function. Pharmacol. Ther. 2007;115:292&#x2013;306. doi: 10.1016/j.pharmthera.2007.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2007.03.005</ArticleId><ArticleId IdType="pubmed">17599430</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryberg H., An J., Darko S., Lustgarten J.L., Jaffa M., Gopalakrishnan V., Lacomis D., Cudkowicz M.E., Bowser R. Discovery and Verification of Amyotrophic Lateral Sclerosis Biomarkers by Proteomics. Muscle Nerve. 2010;42:104&#x2013;111. doi: 10.1002/mus.21683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21683</ArticleId><ArticleId IdType="pmc">PMC2975276</ArticleId><ArticleId IdType="pubmed">20583124</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasojima K., Schwab C., McGeer E.G., McGeer P.L. Human neurons generate C-reactive protein and amyloid P: Upregulation in Alzheimer&#x2019;s disease. Brain Res. 2000;887:80&#x2013;89. doi: 10.1016/S0006-8993(00)02970-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(00)02970-X</ArticleId><ArticleId IdType="pubmed">11134592</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer P.L., McGeer E.G., Yasojima K. Alzheimer disease and neuroinflammation. J. Neural. Transm. Suppl. 2000;59:53&#x2013;57. doi: 10.1007/978-3-7091-6781-6_8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-7091-6781-6_8</ArticleId><ArticleId IdType="pubmed">10961418</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunnon K., Teeling J.L., Tutt A.L., Cragg M.S., Glennie M.J., Perry V.H. Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegeneration. J. Immunol. 2011;186:7215&#x2013;7224. doi: 10.4049/jimmunol.0903833.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0903833</ArticleId><ArticleId IdType="pubmed">21572034</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock B.J., Bender D.E., Kashlan S.R., Figueroa-Romero C., Backus C., Callaghan B.C., Goutman S.A., Feldman E.L. Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 2016;3:e242. doi: 10.1212/nxi.0000000000000242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/nxi.0000000000000242</ArticleId><ArticleId IdType="pmc">PMC4897983</ArticleId><ArticleId IdType="pubmed">27308304</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci C., Marzocchi C., Battistini S. MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis. Cells. 2018;7:219. doi: 10.3390/cells7110219.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells7110219</ArticleId><ArticleId IdType="pmc">PMC6262636</ArticleId><ArticleId IdType="pubmed">30463376</ArticleId></ArticleIdList></Reference><Reference><Citation>Toivonen J.M., Manzano R., Olivan S., Zaragoza P., Garcia-Redondo A., Osta R. MicroRNA-206: A potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS ONE. 2014;9:e89065. doi: 10.1371/journal.pone.0089065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089065</ArticleId><ArticleId IdType="pmc">PMC3930686</ArticleId><ArticleId IdType="pubmed">24586506</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Liu C., Zhu J., Shu P., Yin B., Gong Y., Qiang B., Yuan J., Peng X. MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer&#x2019;s-associated pathogenesis in SAMP8 mice. Neurobiol. Aging. 2012;33:522&#x2013;534. doi: 10.1016/j.neurobiolaging.2010.04.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2010.04.034</ArticleId><ArticleId IdType="pubmed">20619502</ArticleId></ArticleIdList></Reference><Reference><Citation>Majer A., Medina S.J., Niu Y., Abrenica B., Manguiat K.J., Frost K.L., Philipson C.S., Sorensen D.L., Booth S.A. Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice. PLoS Pathog. 2012;8:e1003002. doi: 10.1371/journal.ppat.1003002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003002</ArticleId><ArticleId IdType="pmc">PMC3493483</ArticleId><ArticleId IdType="pubmed">23144617</ArticleId></ArticleIdList></Reference><Reference><Citation>De Andrade H.M., de Albuquerque M., Avansini S.H., Rocha C.d.S., Dogini D.B., Nucci A., Carvalho B., Lopes-Cendes I., Franca M.C., Jr. MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis. J. Neurol. Sci. 2016;368:19&#x2013;24. doi: 10.1016/j.jns.2016.06.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.06.046</ArticleId><ArticleId IdType="pubmed">27538595</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A.H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J.L., Bassel-Duby R., Sanes J.R., Olson E.N. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science. 2009;326:1549&#x2013;1554. doi: 10.1126/science.1181046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaloy C., Liu L., Lee J.A., Su H., Shen F., Yang G.Y., Young W.L., Ivey K.N., Gao F.B. MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors. Cell Stem Cell. 2010;6:323&#x2013;335. doi: 10.1016/j.stem.2010.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2010.02.015</ArticleId><ArticleId IdType="pmc">PMC2851637</ArticleId><ArticleId IdType="pubmed">20362537</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi I., Hama Y., Matsushima M., Hirotani M., Kano T., Hohzen H., Yabe I., Utsumi J., Sasaki H. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis. Mol. Brain. 2015;8:67. doi: 10.1186/s13041-015-0161-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0161-7</ArticleId><ArticleId IdType="pmc">PMC4619470</ArticleId><ArticleId IdType="pubmed">26497046</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiss T. Small nucleolar RNAs: An abundant group of noncoding RNAs with diverse cellular functions. Cell. 2002;109:145&#x2013;148. doi: 10.1016/s0092-8674(02)00718-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(02)00718-3</ArticleId><ArticleId IdType="pubmed">12007400</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J., Wen J., Huang Z., Chen X., Zhang B., Chu L. Small Nucleolar RNAs: Insight Into Their Function in Cancer. Front. Oncol. 2019;9 doi: 10.3389/fonc.2019.00587.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2019.00587</ArticleId><ArticleId IdType="pmc">PMC6629867</ArticleId><ArticleId IdType="pubmed">31338327</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon P.H. Amyotrophic lateral sclerosis: Pathophysiology, diagnosis and management. CNS Drugs. 2011;25:1&#x2013;15. doi: 10.2165/11586000-000000000-00000.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/11586000-000000000-00000</ArticleId><ArticleId IdType="pubmed">21128691</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennigan A., O&#x2019;Callaghan R.M., Kelly &#xc1;.M. Neurotrophins and their receptors: Roles in plasticity, neurodegeneration and neuroprotection. Biochem. Soc. Trans. 2007;35:424&#x2013;427. doi: 10.1042/bst0350424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bst0350424</ArticleId><ArticleId IdType="pubmed">17371291</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakane T., Pardridge W.M. Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity. Pharm Res. 1997;14:1085&#x2013;1091. doi: 10.1023/A:1012117815460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1012117815460</ArticleId><ArticleId IdType="pubmed">9279893</ArticleId></ArticleIdList></Reference><Reference><Citation>Tria M.A., Fusco M., Vantini G., Mariot R. Pharmacokinetics of nerve growth factor (NGF) following different routes of administration to adult rats. Exp. Neurol. 1994;127:178&#x2013;183. doi: 10.1006/exnr.1994.1093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.1994.1093</ArticleId><ArticleId IdType="pubmed">8033961</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda O., Murakami M., Ino H., Yamazaki M., Koda M., Nakayama C., Moriya H. Effects of brain-derived neurotrophic factor (BDNF) on compression-induced spinal cord injury: BDNF attenuates down-regulation of superoxide dismutase expression and promotes up-regulation of myelin basic protein expression. J. Neuropathol. Exp. Neurol. 2002;61:142&#x2013;153. doi: 10.1093/jnen/61.2.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/61.2.142</ArticleId><ArticleId IdType="pubmed">11853017</ArticleId></ArticleIdList></Reference><Reference><Citation>Bemelmans A.P., Husson I., Jaquet M., Mallet J., Kosofsky B.E., Gressens P. Lentiviral-mediated gene transfer of brain-derived neurotrophic factor is neuroprotective in a mouse model of neonatal excitotoxic challenge. J. Neurosci. Res. 2006;83:50&#x2013;60. doi: 10.1002/jnr.20704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.20704</ArticleId><ArticleId IdType="pubmed">16299771</ArticleId></ArticleIdList></Reference><Reference><Citation>Shruthi S., Sumitha R., Varghese A.M., Ashok S., Chandrasekhar Sagar B.K., Sathyaprabha T.N., Nalini A., Kramer B.W., Raju T.R., Vijayalakshmi K., et al. Brain-Derived Neurotrophic Factor Facilitates Functional Recovery from ALS-Cerebral Spinal Fluid-Induced Neurodegenerative Changes in the NSC-34 Motor Neuron Cell Line. Neurodegener. Dis. 2017;17:44&#x2013;58. doi: 10.1159/000447559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000447559</ArticleId><ArticleId IdType="pubmed">27617773</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiaffino L., Bonafede R., Scambi I., Parrella E., Pizzi M., Mariotti R. Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model. Sci. Rep. 2018;8:12875. doi: 10.1038/s41598-018-30659-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-30659-4</ArticleId><ArticleId IdType="pmc">PMC6110772</ArticleId><ArticleId IdType="pubmed">30150770</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremolizzo L., Pellegrini A., Conti E., Arosio A., Gerardi F., Lunetta C., Magni P., Appollonio I., Ferrarese C. BDNF Serum Levels with Respect to Multidimensional Assessment in Amyotrophic Lateral Sclerosis. Neurodegener. Dis. 2016;16:192&#x2013;198. doi: 10.1159/000441916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000441916</ArticleId><ArticleId IdType="pubmed">26745714</ArticleId></ArticleIdList></Reference><Reference><Citation>Prins B.P., Abbasi A., Wong A., Vaez A., Nolte I., Franceschini N., Stuart P.E., Guterriez Achury J., Mistry V., Bradfield J.P., et al. Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study. PLoS Med. 2016;13:e1001976. doi: 10.1371/journal.pmed.1001976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001976</ArticleId><ArticleId IdType="pmc">PMC4915710</ArticleId><ArticleId IdType="pubmed">27327646</ArticleId></ArticleIdList></Reference><Reference><Citation>Keizman D., Rogowski O., Berliner S., Ish-Shalom M., Maimon N., Nefussy B., Artamonov I., Drory V.E. Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis. Acta Neurol. Scand. 2009;119:383&#x2013;389. doi: 10.1111/j.1600-0404.2008.01112.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2008.01112.x</ArticleId><ArticleId IdType="pubmed">18976328</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutedja N.A., van der Schouw Y.T., Fischer K., Sizoo E.M., Huisman M.H., Veldink J.H., Van den Berg L.H. Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2011;82:638&#x2013;642. doi: 10.1136/jnnp.2010.236752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.236752</ArticleId><ArticleId IdType="pubmed">21471184</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel G., Peter R.S., Rosenbohm A., Koenig W., Dupuis L., Rothenbacher D., Ludolph A.C. Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis-results from a population-based ALS registry in Germany. Sci. Rep. 2017;7:4374. doi: 10.1038/s41598-017-04706-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-04706-5</ArticleId><ArticleId IdType="pmc">PMC5491500</ArticleId><ArticleId IdType="pubmed">28663573</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunetta C., Lizio A., Maestri E., Sansone V.A., Mora G., Miller R.G., Appel S.H., Chio A. Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis. JAMA Neurol. 2017;74:660&#x2013;667. doi: 10.1001/jamaneurol.2016.6179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.6179</ArticleId><ArticleId IdType="pmc">PMC5822215</ArticleId><ArticleId IdType="pubmed">28384752</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C.H., Allen K., Oei F., Leoni E., Kuhle J., Tree T., Fratta P., Sharma N., Sidle K., Howard R., et al. Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 2016;3:e244. doi: 10.1212/NXI.0000000000000244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000244</ArticleId><ArticleId IdType="pmc">PMC4897985</ArticleId><ArticleId IdType="pubmed">27308305</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosales C. Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types? Front. Physiol. 2018;9:113. doi: 10.3389/fphys.2018.00113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00113</ArticleId><ArticleId IdType="pmc">PMC5826082</ArticleId><ArticleId IdType="pubmed">29515456</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., King P.H., Si Y., Kwon Y., Varela V., Ibarburu S., Kovacs M., Moura I.C., Beckman J.S., Hermine O., et al. Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. Jci Insight. 2018;3 doi: 10.1172/jci.insight.123249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.123249</ArticleId><ArticleId IdType="pmc">PMC6237484</ArticleId><ArticleId IdType="pubmed">30282815</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z., Chen W., Du Y., Guo Q., Mao Y., Zhou X., Hua D. Serum miR-16 as a potential biomarker for human cancer diagnosis: Results from a large-scale population. J. Cancer Res. Clin. Oncol. 2019;145:787&#x2013;796. doi: 10.1007/s00432-019-02849-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00432-019-02849-8</ArticleId><ArticleId IdType="pubmed">30706130</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Chen J., Sen S. MicroRNA as Biomarkers and Diagnostics. J. Cell Physiol. 2016;231:25&#x2013;30. doi: 10.1002/jcp.25056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.25056</ArticleId><ArticleId IdType="pubmed">26031493</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber J.A., Baxter D.H., Zhang S., Huang D.Y., Huang K.H., Lee M.J., Galas D.J., Wang K. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010;56:1733&#x2013;1741. doi: 10.1373/clinchem.2010.147405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2010.147405</ArticleId><ArticleId IdType="pmc">PMC4846276</ArticleId><ArticleId IdType="pubmed">20847327</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasedieck S., Scholer N., Bommer M., Niess J.H., Tumani H., Rouhi A., Bloehdorn J., Liebisch P., Mertens D., Dohner H., et al. Impact of serum storage conditions on microRNA stability. Leukemia Engl. 2012;26:2414&#x2013;2416. doi: 10.1038/leu.2012.106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/leu.2012.106</ArticleId><ArticleId IdType="pubmed">22504138</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R., Wyles M., Heath P.R., Kazoka M., Wollff H., Shaw P.J., Kirby J. Small RNA Sequencing of Sporadic Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Reveals Differentially Expressed miRNAs Related to Neural and Glial Activity. Front. Neurosci. 2017;11:731. doi: 10.3389/fnins.2017.00731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00731</ArticleId><ArticleId IdType="pmc">PMC5767269</ArticleId><ArticleId IdType="pubmed">29375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori M., Nuzziello N., Introna A., Consiglio A., Licciulli F., D&#x2019;Errico E., Scarafino A., Distaso E., Simone I.L. Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2018;11:288. doi: 10.3389/fnmol.2018.00288.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00288</ArticleId><ArticleId IdType="pmc">PMC6121079</ArticleId><ArticleId IdType="pubmed">30210287</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma M., Juvvuna P.K., Kukreti H., McFarlane C. Mega roles of microRNAs in regulation of skeletal muscle health and disease. Front. Physiol. 2014;5:239. doi: 10.3389/fphys.2014.00239.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00239</ArticleId><ArticleId IdType="pmc">PMC4072100</ArticleId><ArticleId IdType="pubmed">25018733</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasca E., Pegoraro V., Merico A., Angelini C. Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS. Clin. Neuropathol. 2016;35:22&#x2013;30. doi: 10.5414/NP300889.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/NP300889</ArticleId><ArticleId IdType="pubmed">26588026</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R., Goodall E.F., Milo M., Cooper-Knock J., Da Costa M., Hobson E., Kazoka M., Wollff H., Heath P.R., Shaw P.J., et al. Serum miRNAs miR-206, 143&#x2013;3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS) Neurobiol. Aging. 2017;55:123&#x2013;131. doi: 10.1016/j.neurobiolaging.2017.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.03.027</ArticleId><ArticleId IdType="pmc">PMC5455071</ArticleId><ArticleId IdType="pubmed">28454844</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata M., Nakao H., Kiyonari H., Abe T., Aizawa S. MicroRNA-9 regulates neurogenesis in mouse telencephalon by targeting multiple transcription factors. J. Neurosci. 2011;31:3407&#x2013;3422. doi: 10.1523/JNEUROSCI.5085-10.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5085-10.2011</ArticleId><ArticleId IdType="pmc">PMC6623912</ArticleId><ArticleId IdType="pubmed">21368052</ArticleId></ArticleIdList></Reference><Reference><Citation>Dajas-Bailador F., Bonev B., Garcez P., Stanley P., Guillemot F., Papalopulu N. microRNA-9 regulates axon extension and branching by targeting Map1b in mouse cortical neurons. Nat. Neurosci. 2012;15:697&#x2013;699. doi: 10.1038/nn.3082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3082</ArticleId><ArticleId IdType="pubmed">22484572</ArticleId></ArticleIdList></Reference><Reference><Citation>Haramati S., Chapnik E., Sztainberg Y., Eilam R., Zwang R., Gershoni N., McGlinn E., Heiser P.W., Wills A.M., Wirguin I., et al. miRNA malfunction causes spinal motor neuron disease. Proc. Natl. Acad. Sci. USA. 2010;107:13111&#x2013;13116. doi: 10.1073/pnas.1006151107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1006151107</ArticleId><ArticleId IdType="pmc">PMC2919953</ArticleId><ArticleId IdType="pubmed">20616011</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron. Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann P., Levy G., Thompson J.L., Delbene M.L., Battista V., Gordon P.H., Rowland L.P., Levin B., Mitsumoto H. The ALSFRSr predicts survival time in an ALS clinic population. Neurology. 2005;64:38&#x2013;43. doi: 10.1212/01.WNL.0000148648.38313.64.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000148648.38313.64</ArticleId><ArticleId IdType="pubmed">15642901</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda E., Ohashi Y., Tashiro K., Mizuno Y., Kowa H., Yanagisawa N. Reliability and factorial structure of a rating scale for amyotrophic lateral sclerosis. No Shinkei. 1996;48:999&#x2013;1007.</Citation><ArticleIdList><ArticleId IdType="pubmed">8951891</ArticleId></ArticleIdList></Reference><Reference><Citation>Cymbaluk-Ploska A., Chudecka-Glaz A., Pius-Sadowska E., Sompolska-Rzechula A., Chudecka K., Bulsa M., Machalinski B., Menkiszak J. Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer. Dis. Markers. 2017;2017:6589262. doi: 10.1155/2017/6589262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/6589262</ArticleId><ArticleId IdType="pmc">PMC5635290</ArticleId><ArticleId IdType="pubmed">29089666</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F.-X. Genetic weighted k-means algorithm for clustering large-scale gene expression data. BMC Bioinform. 2008;9:1&#x2013;10. doi: 10.1186/1471-2105-9-S6-S12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-9-S6-S12</ArticleId><ArticleId IdType="pmc">PMC2423435</ArticleId><ArticleId IdType="pubmed">18541047</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis G., Jr., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4:P3. doi: 10.1186/gb-2003-4-5-p3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2003-4-5-p3</ArticleId><ArticleId IdType="pubmed">12734009</ArticleId></ArticleIdList></Reference><Reference><Citation>Fresno C., Fernandez E.A. RDAVIDWebService: A versatile R interface to DAVID. Bioinformatics. 2013;29:2810&#x2013;2811. doi: 10.1093/bioinformatics/btt487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt487</ArticleId><ArticleId IdType="pubmed">23958726</ArticleId></ArticleIdList></Reference><Reference><Citation>Jazwa A., Kasper L., Bak M., Sobczak M., Szade K., Jozkowicz A., Sladek K., Dulak J. Differential inflammatory microRNA and cytokine expression in pulmonary sarcoidosis. Arch. Immunol. Exp. 2015;63:139&#x2013;146. doi: 10.1007/s00005-014-0315-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00005-014-0315-9</ArticleId><ArticleId IdType="pmc">PMC4359280</ArticleId><ArticleId IdType="pubmed">25366387</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>